Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.

Abstract

Daily selenium supplementation can suppress the progression of HIV-1 viral burden and provide indirect improvement of CD4 count. The results support the use of selenium as a simple, inexpensive, and safe adjunct therapy in HIV spectrum disease. Trial Registration isrctn.org Identifier: ISRCTN22553118.